Dr Vidya Krishnan is a post-doctoral scientist in the Genetic Epidemiology group led by Professor Sulev Kõks at the Perron Institute and CMMIT, Murdoch University. Her work is focussed on developing antisense therapies for inflammatory diseases including Psoriasis and Atopic dermatitis. She is also working on assessing the efficacy of antisense oligonucleotides to target transposable elements and subfamilies to determine their potential use as therapeutics. Vidya has a first class Master’s degree in Biotechnology and has completed her PhD in 2016 from the School of Anatomy, Physiology and Human Biology at the University of Western Australia.